NUVAIRA, INC.
MINNEAPOLIS, MN · Founded 2008 · CIK 0001461990 · Medtech · Private
Catheter-based system for treating overactive airways in COPD patients
nuvaira.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $164M
- 12 Form D · Mar 2026
- 7 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2008201020122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $83,136 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $10,600,007 | |
| Private capital raised | Form D · SEC | $10,000,000 | |
| Private capital raised | Form D · SEC | $42,000,011 | |
| Private capital raised | Form D · SEC | $4,000,011 | |
| Private capital raised | Form D · SEC | $25,000,004 | |
| Private capital raised | Form D · SEC | $17,417,640 | |
| Private capital raised | Form D · SEC | $15,124,893 | |
| Private capital raised | Form D · SEC | $52,875 | |
| Private capital raised | Form D · SEC | $979,184 | |
| Private capital raised | Form D · SEC | $35,764,878 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1725 | WAVI COMPANY | — | — |
| 1726 | ENURSING, LLC. | — | — |
| 1727 | PREEMIE-PACER, LLC | — | — |
| 1728 | NUVAIRA, INC. | — | $164M |
| 1729 | Nicolaos Christodoulides | — | — |
| 1730 | SURGISENSE CORPORATION | — | — |
| 1731 | Sera Prognostics | — | $150M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Michael CarusiDirector
- Mike CarusiDirector
- MICHAEL CARUSIDirector
- Lincoln CheeDirector
- Mark DeemDirector
- MARK DEEMDirector
- Steven DimmerDirector · Executive Officer
- Geoffrey DuykDirector
- Jacques EssingerDirector
- Jaques EssingerDirector
- Tom GriffinExecutive Officer
- Tim HerbertDirector
- Timothy HerbertDirector
- James Lee Tze WeiDirector
- Yoh-Chie LuDirector
- Martin MayseDirector · Executive Officer
- Edward MorganDirector
- Carolyn NgDirector
- Kirk NielsenDirector
- KIRK NIELSENDirector
- Robert O'HollaDirector
- Hank PlainDirector
- Henry PlainDirector
- HENRY PLAINDirector
- Gary RieschelDirector
- Jonathan RootDirector
- Alexander SchmitzDirector
- Christopher ShenDirector
- Doug SissonDirector
- Dave StassenDirector
- David StassenDirector
- DAVID STASSENDirector
- David Van MeterDirector
- Dennis WahrDirector · Executive Officer
- DENNIS WAHRDirector · Executive Officer
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.